Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-12 | Amended | $20,000,000 | $10,000,000 | Other | 06b | SEC link |
| 2024-07-01 | New | $10,000,000 | $10,000,000 | Other | 06b | SEC link |
| 2023-11-20 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2022-09-26 | New | $9,999,999 | $9,999,999 | Equity Only | 06b | SEC link |
| 2021-10-29 | Amended | $8,575,741 | $2,000,000 | Equity Only | 06b | SEC link |
| 2020-11-09 | New | $6,575,741 | $6,575,741 | Equity Only | 06b | SEC link |
| 2020-06-18 | New | $100,000 | $100,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Houman Hemmati | Director |
| Wolfgang Hofmann | Director |
| Jan Jensen | Director, Executive |
| Michael Kaufman | Director |
| David Llewellyn | Director, Executive |
| Craig Nemiroff | Director |
| Magnus Persson | Director |
| Joshua Snow | Executive |
| Div Trivedi | Executive |
| Divya Trivedi | Executive |